Kendall Davis, MPH (@kendalljd28) 's Twitter Profile
Kendall Davis, MPH

@kendalljd28

Rare Disease Patient Advocate. Lets spread awareness for the OVER 7,000 RARE DISEASES and those they impact. Together we are strong. Lets change the world!!

ID: 1003096454

calendar_today11-12-2012 02:17:30

671 Tweet

927 Followers

1,1K Following

Dr. Tracy Dixon-Salazar (@tracydixonsalaz) 's Twitter Profile Photo

Me at the end of #RareDiseaseTruth month. 3 days left. 28 personal truths posted in total. Countless others read and felt deep in my bone weary core. I love my #RareDiseases and LGS Foundation community. I’d be lost without you. Bring your own wine though. I don’t have extra. 🙂

David Fajgenbaum, MD (@davidfajgenbaum) 's Twitter Profile Photo

#RareDisease discussion tonight with Medidata Glen de Vries on #CTSM reminds me of how critical unlocking every single data point and sample is for rare disease research...

Neena Nizar (@neenanizar) 's Twitter Profile Photo

Even when the pain was at its worst, his wish was for eveyone else to be free of all pain. This boy shows me every day what it looks like to think about others. #RareDiseaseTruth

Even when the pain was at its worst, his wish was for eveyone else to be free of all pain.

This boy shows me every day what it looks like to think about others.

#RareDiseaseTruth
Kendall Davis, MPH (@kendalljd28) 's Twitter Profile Photo

The good thing about having a toddler? I got to wear multiple #raredisease shirts today for #RareDiseaseDay2021. Ending the day with KIF1A.ORG Also. Getting to dress@that toddler up like a zebra!

The good thing about having a toddler? I got to wear multiple #raredisease shirts today for #RareDiseaseDay2021. Ending the day with <a href="/KIF1A/">KIF1A.ORG</a> 
Also. Getting to dress@that toddler up like a zebra!
Neena Nizar (@neenanizar) 's Twitter Profile Photo

"The lives of rare disease patients are as important as the lives of covid patients!" - Dr. Chris Austin NCATS #RDDNIH Hallelujah! #RareDiseaseTruth

Luke Rosen (@lukebrosen) 's Twitter Profile Photo

1/4: I’m just gonna say it because our nonprofit KIF1A.ORG has received proposals from several early startups (with big payrolled staffs) to repurpose publicly accessible compound libraries. The proposals for each ranged btw $250K-$1.5M. With the word “proprietary” all over them.

Luke Rosen (@lukebrosen) 's Twitter Profile Photo

2/4: We’re a patient-driven org running on hard earned grants & lemonade stands. We don’t want a percentage of the output (you probably even already have a provisional patent). The only ROI we’re interested in is seeing our kids walk. All our tools are publicly available for you.

Luke Rosen (@lukebrosen) 's Twitter Profile Photo

3/4: so this will be unpopular, I know. But, Dear certain startups: the rare disease community is starting to feel a bit preyed on. If you really believe in your science, invest in your company, dont ask patients & families desperate for anything to do it for you while you

Luke Rosen (@lukebrosen) 's Twitter Profile Photo

4/4: staff up, go on million $ raises, & tell us we can’t share output. So, step up & believe in yourselves. You’re the company. Cross the finish line & find treatments for our kids. That’s all we care about, & we don’t have millions. Collaborate & help us. We’d be very thankful.

Kendall Davis, MPH (@kendalljd28) 's Twitter Profile Photo

I can’t wait to moderate this incredible panel discussion! Check it out. #Accessibility #clinicaltrials #RareDisease xtalks.com/webinars/rare-…

ICON Plc (@iconplc) 's Twitter Profile Photo

Rare disease populations are intersectional. Join us as we explore ways to improve engagement, accessibility and inclusion by planning for disability in #raredisease clinical trial design. bit.ly/rare-disease-w…

Rare disease populations are intersectional. Join us as we explore ways to improve engagement, accessibility and inclusion by planning for disability in #raredisease clinical trial design. bit.ly/rare-disease-w…